Michaelson Jennifer reported option exercise involving 3,805 derivative units of Cullinan Therapeutics, Inc. at $0.00 for $0 on Nov 5, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Scientific Officer
Chief Scientific Officer
Filed Nov 6, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
$0Shares × reported price
Shares traded
3,805Stock Option (Right to Buy)
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
75,182Direct
Trade date
Nov 5, 2026Option exercise
Filed
Nov 6, 2026, 5:00 PM ET1-day reporting delay
Accession
0001193125-26-452004Code M · Transaction 395116
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Nov 5, 2026Sell4,000$12.36−$49,440Trade 395115
Nov 5, 2026Option exercise3,805$4.30$16,361.50Trade 395114
3 transaction rows in this filing. Joint filers share the same rows.

CGEM price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CGEM · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +9.5%1w ago 0%1d ago 0%
Returns since7d −31%30d90d180d1y

Footnotes in full

F1: Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on August 7, 2025. F2: 25% of the shares vested on July 4, 2020, and the remaining shares vested in 36 equal monthly installments thereafter.